MedPath

Power-speed-endurance Profile (Cycling/Rowing) : Optimize Performance of the French Athletes at the Paris Olympics 2024

Not Applicable
Completed
Conditions
Healthy Volunteers
Performance
Interventions
Other: Hypoxia
Registration Number
NCT05314543
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

As part of the preparation at the Paris 2024 Olympic Games, the French rowing and cycling federations and a consortium of researchers met to reach an ultimate goal: to increase the number of medals in these two disciplines for Paris 2024 Olympics.

Detailed Description

The objective of this study is to evaluate the maximum capacity of power production of athletes by describing their power-endurance profile and the physiological factors underlying this maximum power generation capacity. These assessments will guide coaches and athletes for:

1. the best use of athletes' physical abilities (for race strategy, cycling gear ratio or rowing levers)

2. adaptation of training program to improve the maximum capacity of power production of the athletes, in order to increase the number of medals at the Paris Olympics 2024.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • experienced, well-trained (national to international level) rowers and cyclists
  • written consent
Exclusion Criteria
  • taking medications interfering with measured parameters
  • contraindication to competitive sport practice
  • currently participating in an other structured exercise program
  • muscular, bone or joint injuries
  • neurologic disease
  • pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Track cyclists and rowers (males and females)HypoxiaAll female and male rowing and track cycling athletes at the national or international national or international level, registered in a selection process and likely to represent France at the likely to represent France at the 2024 Olympics will be asked to take part to take part in this study.
Primary Outcome Measures
NameTimeMethod
Speed in a fatigue-free conditionMonth : 3

V0i measurement

Maximum force produced at zero speed at the end of the 3 min.Month : 3

F0e measurement

Maximum force produced at zero speed in a fatigue-free conditionMonth : 3

F0i measurement

Speed up produced at the end of the 3 min.Month : 3

V0e measurement

Secondary Outcome Measures
NameTimeMethod
Maximum force produced at zero speed at the end of the 3 min after bicarbonate ingestionMonth : 3

F0e measurement

Speed up produced at the end of the 3 min after bicarbonate ingestionMonth : 3

V0i measurement

Maximal oxygen uptake (VO2max) after bicarbonate ingestionAt inclusion

Cardiac stress test

Maximal Ventilation (VEmax) after bicarbonate ingestionAt inclusion

Cardiac stress test

Cardiac output (QCmax) after bicarbonate ingestionAt inclusion

Cardiac stress test

Maximal cardiac frequency (fcmax) after bicarbonate ingestionAt inclusion

Cardiac stress test

Fibre type determination after bicarbonate ingestionMonth : 2

Muscle biopsy of the vastus lateralis

Microvasculature analysis after bicarbonate ingestionMonth : 2

Muscle biopsy of the vastus lateralis

Speed in a fatigue-free condition after bicarbonate ingestionMonth : 3

V0i measurement

Rate of force developmentMonth : 9

Comparison of force development

Evoked forces (N)Month : 9

Ratio of evoked force at low and high frequencies

Maximum force produced at zero speed in a fatigue-free condition after bicarbonate ingestionMonth : 3

F0i measurement

Maximal oxygen uptake (VO2max)At inclusion

Cardiac stress test

Maximal Ventilation (VEmax)At inclusion

Cardiac stress test

Cardiac output (QCmax)At inclusion

Cardiac stress test

Maximal cardiac frequency (fcmax)At inclusion

Cardiac stress test

Fibre type determinationMonth : 2

Muscle biopsy of the vastus lateralis

Microvasculature analysisMonth : 2

Muscle biopsy of the vastus lateralis

Muscle enzyme activity (Phosphofructokinase (PFK), lactate dehydrogenase (LDH), citrate synthase (CS) et cyclo-oxygenase (COx))Month : 2

Muscle biopsy of the vastus lateralis

Maximal voluntary force (N)Month : 9

Comparison before and after exercise

Muscle enzyme activity (Phosphofructokinase (PFK), lactate dehydrogenase (LDH), citrate synthase (CS) et cyclo-oxygenase (COx)) after bicarbonate ingestionMonth : 2

Muscle biopsy of the vastus lateralis

Maximal voluntary force (N) after bicarbonate ingestionMonth : 9

Comparison before and after exercise

Rate of force development after bicarbonate ingestionMonth : 9

Comparison of force development

Evoked forces (N) after bicarbonate ingestionMonth : 9

Ratio of evoked force at low and high frequencies

Trial Locations

Locations (3)

CEPART

🇫🇷

Le Bourget-du-Lac, France

Chu Nantes

🇫🇷

Nantes, France

Chu Saint-Etienne

🇫🇷

Saint-Étienne, France

© Copyright 2025. All Rights Reserved by MedPath